Aroa Biosurgery Limited (ARX.AX)
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
0.57+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-10.9%
The outlook
Aroa Biosurgery Limited currently reads as leaning bearish based on below its 50- & 200-day averages, 25% of the way from its 52-week low to high, avg target +92% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range25% of the way from its 52-week low to high
Price targetAvg target +92% vs current price
Analyst price target
~12-month · 3 analysts1.09average target+91.8% vs now
Now 0.57
Low 0.80High 1.38
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$197.6M
52-wk high
0.80
52-wk low
0.50
50-day avg
0.61
200-day avg
0.65
Trailing P/E
57.0